Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Stein

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
The Prostate|October 25, 2013
Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesionNitu Bansal, Stephani Davis, Irina Tereshchenko, et al.
Clinical Genitourinary Cancer|September 5, 2018
Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell CarcinomaMichael E Hurwitz, Paul Markowski, Xiaopan Yao, et al.
Cancer Medicine|May 8, 2018
Safety and pharmacokinetics of veliparib extended-release in patients with advanced solid tumors: a phase I studyTheresa L Werner, Jasgit Sachdev, Elizabeth M Swisher, et al.
Frontiers in Oncology|August 28, 2020
Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation TherapyJulie N Graff, Mark N Stein, Rishi Surana, et al.
Endocrinology|June 12, 2019
Dihydrotestosterone Increases Cytotoxic Activity of Macrophages on Prostate Cancer Cells via TRAILGeun Taek Lee, Jeong Hyun Kim, Seok Joo Kwon, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805)Mark N Stein, Yu-Hui Chen, Michael A Carducci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Correction: Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate CancerAnna C Ferrari, Joshi J Alumkal, Mark N Stein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate CancerAnna C Ferrari, Joshi J Alumkal, Mark N Stein, et al.
Journal of Genitourinary Disorders|February 5, 2019
Correlation of Prostate Cancer CHD1 Status with Response to Androgen Deprivation Therapy: a Pilot StudyAlexandra L Tabakin, Evita T Sadimin, Irina Tereshchenko, et al.
Cancer Chemotherapy and Pharmacology|May 3, 2013
Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumorsAntoinette R Tan, Darlene G Gibbon, Mark N Stein, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
The Prostate|October 25, 2013
Enrichment of human prostate cancer cells with tumor initiating properties in mouse and zebrafish xenografts by differential adhesionNitu Bansal, Stephani Davis, Irina Tereshchenko, et al.
Clinical Genitourinary Cancer|September 5, 2018
Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell CarcinomaMichael E Hurwitz, Paul Markowski, Xiaopan Yao, et al.
Cancer Medicine|May 8, 2018
Safety and pharmacokinetics of veliparib extended-release in patients with advanced solid tumors: a phase I studyTheresa L Werner, Jasgit Sachdev, Elizabeth M Swisher, et al.
Frontiers in Oncology|August 28, 2020
Phase II Study of Ipilimumab in Men With Metastatic Prostate Cancer With an Incomplete Response to Androgen Deprivation TherapyJulie N Graff, Mark N Stein, Rishi Surana, et al.
Endocrinology|June 12, 2019
Dihydrotestosterone Increases Cytotoxic Activity of Macrophages on Prostate Cancer Cells via TRAILGeun Taek Lee, Jeong Hyun Kim, Seok Joo Kwon, et al.
American Journal of Clinical Oncology|February 22, 2019
Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805)Mark N Stein, Yu-Hui Chen, Michael A Carducci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2019
Correction: Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate CancerAnna C Ferrari, Joshi J Alumkal, Mark N Stein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate CancerAnna C Ferrari, Joshi J Alumkal, Mark N Stein, et al.
Journal of Genitourinary Disorders|February 5, 2019
Correlation of Prostate Cancer CHD1 Status with Response to Androgen Deprivation Therapy: a Pilot StudyAlexandra L Tabakin, Evita T Sadimin, Irina Tereshchenko, et al.
Cancer Chemotherapy and Pharmacology|May 3, 2013
Effects of ketoconazole and esomeprazole on the pharmacokinetics of pazopanib in patients with solid tumorsAntoinette R Tan, Darlene G Gibbon, Mark N Stein, et al.
Pageof 10